Analytical Development and Product Characterization Strategies

Monday, February 25, 2013, 4:00pm-6:10pm PST

In this session talks will be focused on new, more streamlined approaches to analytical method development and transfer for both product release and characterization. Examples would include eliminating some product release assays through more powerful MS methods, using platform analytical methods for speed of development and transfer and other strategies for rapid method development.

 

Session Co-Chairs:

  • Mike Washabaugh,  MedImmune

  • Laura Bass, Pfizer

Confirmed Speakers

  • Rob Dufield, Pfizer: Analytical Strategies Enabling Expedited Development of Therapeutic mAbs

  • Qinjian Zhao, Xiamen University: Structural and Functional Analysis of Recombinant Virus-like Particles (VLP's)

  • Kuldip Sra, MedImmune: Development of a Seasonal Vaccine

Qinjian Zhao

Dr. Qinjian Zhao got his undergraduate and graduate training in pharmaceutical sciences in Peking University (1981 – 1989). Then he moved on to pursue a Ph.D. degree in Biochemistry in The Catholic University of America, Washington, DC (1989-1993).   Subsequently, he did post-doctoral training in School of Medicine, Johns Hopkins University (1993-1997), focusing on protein structure and enzyme function. In 1997, Qinjian joined Merck Research Lab, Bioprocess R&D, working on the analytical and structural aspects of recombinant protein based vaccines, such as Recombivax HB and HPV vaccine...